학회지

권호별 검색

  • HOME
  • 학회지
  • 학회지
  • 권호별 검색
Original Article
Dementia and Neurocognitive Disorders 2018: 17: 2: 41-49

전문보기

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
YoungSoon Yang ,1 Vo Van Giau,2 Seong Soo A. An,2 SangYun Kim 3
1Department of Neurology, Veterans Health Service Medical Center, Seoul, Korea 2Department of Bionano Technology, Gachon University, Seongnam, Korea 3Department of Neurology, Seoul National University College of Medicine & Neurocognitive Behavior Center, Seoul National University Bundang Hospital, Seongnam, Korea
Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
YoungSoon Yang ,1 Vo Van Giau,2 Seong Soo A. An,2 SangYun Kim 3
1Department of Neurology, Veterans Health Service Medical Center, Seoul, Korea 2Department of Bionano Technology, Gachon University, Seongnam, Korea 3Department of Neurology, Seoul National University College of Medicine & Neurocognitive Behavior Center, Seoul National University Bundang Hospital, Seongnam, Korea
Background and Purpose: During the Vietnam War, many Korean soldiers were exposed
to Agent Orange. Until now, there existed only limited evidence of association between
exposure to Agent Orange and Alzheimer's disease (AD). The main pathological feature of
AD is brain amyloidosis. To explore the pathophysiological characteristic of AD with Agent
Orange exposure, we compared newly developed amyloid beta (Aβ) oligomer levels in plasma
between AD with Agent Orange exposure and without exposure.
Methods: We recruited 48 AD patients with Agent Orange exposure and 66 AD patients
without Agent Orange. Using the Multimer Detection System technique, which was based
on an enzyme-linked immunosorbent assay, we measured Aβ oligomers in the plasma of
study subjects.
Results: Compared to normal control patients, plasma Aβ oligomer levels were higher in
AD patients regardless of history of Agent Orange exposure. However, AD patients with
Agent Orange exposure showed higher plasma Aβ oligomer levels than AD patients without
Agent Orange.
Discussion: This study showed higher plasma Aβ oligomer levels in AD patients with Agent
Orange exposure compared to AD patients without Agent Orange. This finding suggests the
possibility of a different pathophysiology of AD patients with Agent Orange exposure from
AD patients without Agent Orange.
Key Words: Agent Orange; Alzheimer's Disease; Plasma Aβ Oligomer
대한치매학회지 (Dementia and Neurocognitive Disorders)